Skip to main content
Log in

Plasma 3α-androstanediol glucuronide in precocious adrenarche

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

The aim was to study 3α-androstane-diol glucuronide (3AG) plasma levels and its relationship with 5-ene and 4-ene steroids in children with the benign form of precocious pubarche (precocious adrenarche). Sixty-five children with precocious adrenarche (PA), aged 3.6–8.2 yr (55 girls and 10 males) and 15 normal age-matched children were studied. We evaluated plasma androstenedione (A), dehydroepiandrosterone (DHA), its sulfate (DHA-S), testosterone (T), dihydrotestosterone (DHT), its glucuronide (DHTG), 3α-androstanediol (3Ad) and its glucuronide (3AG) in all subjects. All androgens are expressed as mean±SD. We found significantly higher plasma levels not only in glandular androgens but also in peripheral androgens (A, 2.4±1.5 nM vs 0.79±0.46 nM, p<0.001; DHA, 9.8±4.9 vs2.7±0J6 ng/dl, p<0.001; DHA-S, 3.4±2 μM vs 2.4±0.65 μM, p<0.05; T, 0.74±0.5 nM vs 0.4±0.1 nM, p<0.001; DHT, 0.36±0.13 nM vs 0.12±0.05 nM, p<0.001; 3Ad, 0.13±0.1 nM vs 0.054±0.03 nM, p<0.001; DHTG, 0.5±0.3 nM vs 0.26±0.09 nM p<0.01). As far as the plasma 3AG levels are concerned we found significantly higher values in PA with respect to controls (1.17±0.7 nM vsO.61±0.04 nM, p<0.01), suggesting that 3AG may be considered a marker of skin androgen utilization. 3AG plasma levels correlated better with serum A (p<0.002, r=0.42) and T (p<0.003, r=0.41) than with DHA (p<0.03, r=0.37), suggesting that both 4-ene and 5-ene androgens contribute to its production, but its plasma levels are better correlated with 4-ene than with 5-ene steroids. Furthermore 3AG plasma levels correlated with both 3Ad (p<0.01, r=0.4) and DHTG (p<0.001, r=0.47); no correlation was found with DHT, suggesting that in this condition 3AG may originate, in peripheral tissue either via the unconjugated pathway DHT→3Ad→3AG or via the conjugated pathway DHT→DHTG→3AG.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Meikle A.W., Stringham Y.D., Wilson D.E., Doman I. 5a-reduced androgens in men and hirsute women: role of adrenals and gonads. J. Clin. Endocrinol. Metab. 45:969, 1979.

    Article  Google Scholar 

  2. Moghissi E., Ablan F., Horton R. Origin of plasma Androstanediol Glucuronide in men. J. Clin. Endocrinol. Metab. 59:417, 1984.

    Article  PubMed  CAS  Google Scholar 

  3. Horton R., Hawks D., Lobo R. 3α, 17p-androstanediol glucuronide in plasma. A new marker of androgen action in idiopathic hir-sutism. J. Clin. Invest. 62:1203, 1982.

    Article  Google Scholar 

  4. Greep N., Hoopes M., Horton R. Androstanediol glucuronide plasma clearance and production rates in normal and hirsute women. J. Clin. Endocrinol. Metab. 62:22, 1986.

    Article  PubMed  CAS  Google Scholar 

  5. Toscano V., Sciarra F., Adamo M.V., Petrangeli E., Foli S., Caiola S., Conti C. Is 3α-androstanediol a marker of peripheral hir-sutism? Acta Endocrinol.(Copenh.) 99:314, 1982.

    CAS  Google Scholar 

  6. Abraham G., Chakmakjian Z.H. Plasma steroids in hirsutism. Obstet. Gynecol. 44:171, 1973.

    Google Scholar 

  7. Kirschner M.A., Samojlik E., Small E. Clinical usefulness of plasma androstanediol glu-curonide measurements in women with idiopathic hirsutism. J. Clin. Endocrinol. Metab. 65:597, 1987.

    Article  PubMed  CAS  Google Scholar 

  8. Horton R., Imperato McGinley J. Androstanediol glucuronide (3α-diol) in plasma is a unique marker in disorders of peripheral androgen production and action in male pseudo-hermaphroditism. In: Serio M., Martini L. (Eds.), Sexual Differentiation. Raven Press, New York, 1984, P.261.

    Google Scholar 

  9. Morimoto T., Edmiston A., Horton R. Studies on the origin of androstanediol and an-drostanediol glucuronide in young and elderly men. J. Clin. Endocrinol. Metab. 52:772, 1981.

    Article  PubMed  CAS  Google Scholar 

  10. Horton R., Hawks D., Lobo R. 3α,17β-androstanediol glucuronide in plasma: a marker of androgen action in idiopathic hirsutism. J. Clin. Invest. 69:1203, 1982.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  11. Deslypere J.P., Sayed A., Punjabi U., Verdonck L, Vermeulen A. Plasma 5α-androstane-3α,17β-diol and urinary 5α-androstane-3α,17β-diol glucuronide, parameters of peripheral androgen action: a comparative study. J. Clin. Endocrinol. Metab. 54:386, 1982.

    Article  PubMed  CAS  Google Scholar 

  12. Toscano V. Dihydrotestosterone metabolism. Clin. Endocrinol. Metab. 15:279, 1986.

    Article  PubMed  CAS  Google Scholar 

  13. Ertel N.H., Akgun S., Samojlik E., Kirschner M.A., Imperato-McGinley J. Decreased 3α-androstanediol glucuronide levels in plasma and random urines in male pseudohermaphroditism caused by 5α- reductase deficiency. Metabolism 38:817, 1989.

    Article  PubMed  CAS  Google Scholar 

  14. Mauvais-Jarvis P., Bercovici J.P., Crepy O., Gauthier F. Studies on testosterone metabolism in subjects with testicular feminization syndrome. J. Clin. Invest. 49:31, 1970.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  15. Lobo R.A., Wellington L.P., Gentzschein E., Serafini P.C. Catalino J.A., Paulson R.J., Horton R. Production of 3α-androstanediol glucuronide in hu man genital skin. J. Clin. Endocrinol. Metab. 65:711, 1987.

    Article  PubMed  CAS  Google Scholar 

  16. Gompel A., Wright F., Kuttenn F., Mauvais Jarvis P. Contribution of plasma androstenedione to 5α-an-drostanediol glucuronide in women with idiopathic hirsutism. J. Clin. Endocrinol. Metab. 62:441, 1986.

    Article  PubMed  CAS  Google Scholar 

  17. Greep N., Hooper M., Horton R. Evidence for the role of androstenedione as a pre-cursor for plasma DHT and androstanediol glu-curonide in normal and hirsute women. 67th Annual Meeting of the Endocrine Society 261, 1985.

  18. Giagulli V.A., Verdonck L, Giorgino R., Vermulen A. Precursors of plasma androstanediol and androgen- glucuronides in women. J. Steroid Biochem. 33:935, 1989.

    Article  PubMed  CAS  Google Scholar 

  19. Mauvais Jarvis P., Baulieu E.E. Studies on testosterone metabolism IV. Urinary 5α-and 5β-androstanediols and testosterone glu-curonide from testosterone and dihydroisoandros-terone sulfate in normal people and hirsute women. J. Clin. Endocrinol. Metab. 25:1167, 1965.

    Article  PubMed  CAS  Google Scholar 

  20. Brochu M., Belanger A., Tremblay R. Plasma levels of C-19 steroids and 5α-reduced steroids glucuronides in hyperandrogenic and idio-pathic hirsute women. Fertil. Steril. 43:948, 1987.

    Google Scholar 

  21. Brochu M., Belanger A. Increase in plasma steroid glucuronide levels in men from infancy to adulthood. Fertil. Steril:64:1283, 1987.

    CAS  Google Scholar 

  22. Riddick L.M., Garibaldi L.R., Wang M.E., Senne A.R., Klimah O.E., Clark AT., Levine L.S., Oberfield S.E., Pang S. 3α-androstanediol glucuronide in premature and normal pubarche. J. Clin. Endocrinol. Metab 72:46, 1991.

    Article  PubMed  CAS  Google Scholar 

  23. Horton R., Endres D., Galmarini M. Ideal conditions for hydrolysis of androstane 3α, 17(3- diol glucuronide in plasma. J. Clin. Endocrinol. Metab. 59:1027, 1984.

    PubMed  CAS  Google Scholar 

  24. Balducci R., Toscano V. Bioactive and peripheral androgens in prepubertal simple hypertrichosis. Clin. Endocrinol. (Oxf.) 33:407, 1990.

    Article  CAS  Google Scholar 

  25. Toscano V., Horton R. Circulating dihydrotestosterone may not reflect pe-ripheral formation. J. Clin. Invest. 79:1653, 1987.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Balducci, R., Finocchi, G., Mangiantini, A. et al. Plasma 3α-androstanediol glucuronide in precocious adrenarche. J Endocrinol Invest 16, 117–121 (1993). https://doi.org/10.1007/BF03347661

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347661

Key-word

Navigation